Cargando…
Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease
INTRODUCTION: Because apolipoprotein E (APOE) genotypes are known risk factors for Alzheimer's disease (AD), they have been measured in clinical trial participants to determine their effect on treatment outcome. METHODS: We determined APOE genotypes in a subset of subjects (N = 415) who partici...
Autores principales: | Belitskaya-Lévy, Ilana, Dysken, Maurice, Guarino, Peter, Sano, Mary, Asthana, Sanjay, Vertrees, Julia E., Pallaki, Muralidhar, Llorente, Maria, Love, Susan, Schellenberg, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118101/ https://www.ncbi.nlm.nih.gov/pubmed/30175228 http://dx.doi.org/10.1016/j.trci.2018.06.001 |
Ejemplares similares
-
Measuring informed consent capacity in an Alzheimer's disease clinical trial
por: Guarino, Peter D., et al.
Publicado: (2016) -
Apolipoprotein E Genotype e2: Neuroprotection and Its Limits
por: Kim, Hyun, et al.
Publicado: (2022) -
Apolipoprotein E4 genotype compromises brain exosome production
por: Peng, Katherine Y, et al.
Publicado: (2019) -
Apolipoprotein E genotype in Korean schizophrenic patients.
por: Lee, M. K., et al.
Publicado: (2001) -
Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly
por: Haan, Mary N., et al.
Publicado: (2010)